Asklepios Kliniken GmbH is a German hospitals company, one of Germany's three largest operators of private hospitals. It employs more than 45,000 people, and owns 150 hospitals worldwide. Asklepios Kliniken was founded by German billionaire Bernard Broermann, who opened his first hospital in 1984.

During the past decade, Asklepios Kliniken GmbH & Co. KGaA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Kliniken GmbH & Co. KGaA" #1 collaborator was "Asklepios Kliniken GmbH & Co. KGaA" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Kliniken GmbH & Co. KGaA" are "COVID-19" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Asklepios Kliniken GmbH & Co. KGaA" in a lesser frequency.

Most popular intervention types in "Asklepios Kliniken GmbH & Co. KGaA" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Kliniken GmbH & Co. KGaA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Kliniken GmbH & Co. KGaA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Asklepios Kliniken GmbH & Co. KGaA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Kliniken GmbH & Co. KGaA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".